Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.

Share:
More In Business
U.S. Government Moves to Stop Potential Banking Crisis
The Treasury Department, Federal Reserve, and Federal Deposit Insurance Corporation said all depositors at the failed Silicon Valley Bank could access all their money quickly, even as another major bank was shut down.
Load More